🇺🇸 FDA
Pipeline program

UB-421

UBP-A308-HIV

Phase 3 mab active

Quick answer

UB-421 for HIV-1 Infection is a Phase 3 program (mab) at United Therapeutics Europe Ltd with 4 ClinicalTrials.gov record(s).

Program details

Company
United Therapeutics Europe Ltd
Indication
HIV-1 Infection
Phase
Phase 3
Modality
mab
Status
active

Clinical trials